Aleta Shiff serves as Executive at NeuBase Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Aleta Shiff has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 18, 2023 involved transacting 0 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Sep 18, 2023 | NBSE | $0 | Other | 0 | $N/A | Discretionary |
Aleta Shiff currently holds 192,481 shares of NeuBase Therapeutics, Inc. (NBSE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Aleta Shiff has been a net neutral trader of NBSE stock. They have purchased $0 and sold $0 worth of shares.
Aleta Shiff's most recent insider trade was on Sep 18, 2023, when they sold 0 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted